Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny

NACompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 1, 2018

Study Completion Date

September 5, 2022

Conditions

Crohn DiseaseColitis, Ulcerative

Interventions

DEVICE

Home Based Fecal Calprotectin

Home Based Fecal Calprotectin measurement at weeks 0, 4 and 8

Trial Locations (1)

UZ Leuven, Leuven

All Listed Sponsors

collaborator

Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW

OTHER

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT02634060 - Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny | Biotech Hunter | Biotech Hunter